Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 7.84
-0.03 (-0.38%)
Oct 23, 2026, 12:54 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 13.07 billion as of October 22, 2026. It is the 6,675th most valuable company in the world and the 1,194th biggest in China. Its market cap has decreased by 23.64% in one year.
Market Cap
13.07B
Enterprise Value
11.89B
Revenue
2.45B
Global Rank
Country Rank
#1,194 China
PE Ratio
18.66
ChartMarket Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 13.07B, an increase of 210.70%. That is a compound annual growth rate of 6.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 13.07B | -18.14% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 16.34B |
| Sinocelltech Group | 15.66B |
| HitGen | 15.10B |
| BrightGene Bio-Medical Technology | 13.80B |
| Sino Biological,Inc. | 13.73B |
| Jinyu Bio-technology | 13.60B |
| GemPharmatech | 12.38B |
| Nanjing Vazyme Biotech | 11.91B |